JPS6129353B2 - - Google Patents

Info

Publication number
JPS6129353B2
JPS6129353B2 JP9640377A JP9640377A JPS6129353B2 JP S6129353 B2 JPS6129353 B2 JP S6129353B2 JP 9640377 A JP9640377 A JP 9640377A JP 9640377 A JP9640377 A JP 9640377A JP S6129353 B2 JPS6129353 B2 JP S6129353B2
Authority
JP
Japan
Prior art keywords
dihydrocarbostyryl
compound
reaction
general formula
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP9640377A
Other languages
Japanese (ja)
Other versions
JPS5430180A (en
Inventor
Takao Nishi
Takashi Ueda
Kazuyuki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP9640377A priority Critical patent/JPS5430180A/en
Publication of JPS5430180A publication Critical patent/JPS5430180A/en
Publication of JPS6129353B2 publication Critical patent/JPS6129353B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は新規な3・4−ジヒドロカルボスチリ
ル誘導体に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel 3,4-dihydrocarbostyryl derivatives.

本発明の化合物は新規化合物であつて、一般式 〔式中Rは水素原子又は炭素数1〜3のアルキル
基を、Xはハロゲン原子を夫々示す。〕で表わさ
れる。該化合物は抗菌作用、消炎作用、血小板凝
集抑制作用を有し、抗菌剤、消炎剤、血栓予防薬
等として有用である。
The compound of the present invention is a new compound and has the general formula [In the formula, R represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and X represents a halogen atom. ]. The compound has antibacterial action, anti-inflammatory action, and platelet aggregation-inhibiting action, and is useful as an antibacterial agent, anti-inflammatory agent, antithrombotic agent, and the like.

上記一般式〔〕に於て、Rで示される炭素数
1〜3のアルキル基としては具体的にはメチル、
エチル、プロピル及びイソプロピル基である。ま
たXで示されるハロゲン原子としては塩素原子、
臭素原子、沃素原子等を例示できる。
In the above general formula [], the alkyl group having 1 to 3 carbon atoms represented by R is specifically methyl,
Ethyl, propyl and isopropyl groups. In addition, the halogen atom represented by X is a chlorine atom,
Examples include bromine atom and iodine atom.

本発明の化合物は種々の方法にて製造される
が、その好ましい一例としては例えば下式に示す
如くして製造される。
The compound of the present invention can be produced by various methods, and a preferred example thereof is as shown in the following formula.

即ち一般式〔〕で表わされる公知の6−(3
−ハロゲノプロポキシ)−3・4−ジヒドロカル
ボスチリル誘導体、例えば6−(3−ブロモプロ
ポキシ)−3・4−ジヒドロカルボスチリル、6
−(3−クロロプロポキシ)−3・4−ジヒドロカ
ルボスチリル等と一般式〔〕で表わされる公知
のアミン、例えばピリジン、α−ピコリン、3−
エチルピリジン、2−プロピルピリジン、4−イ
ソプロピルピリジン等とを反応させることにより
本発明化合物が製造される。
That is, the well-known 6-(3
-halogenopropoxy)-3,4-dihydrocarbostyryl derivatives, such as 6-(3-bromopropoxy)-3,4-dihydrocarbostyryl, 6
-(3-chloropropoxy)-3,4-dihydrocarbostyryl, etc., and known amines represented by the general formula [], such as pyridine, α-picoline, 3-
The compound of the present invention is produced by reacting with ethylpyridine, 2-propylpyridine, 4-isopropylpyridine, etc.

本発明における上記反応は、無溶媒で或いは溶
媒中で行なわれる。ここで溶媒としては、反応に
関与しないものであればいずれも使用できる。代
表的溶媒を例示すれば、メタノール、エタノー
ル、プロパノール、イソプロパノール、ブタノー
ル、エチレングリコール等のアルコール類;ジメ
チルエーテル、テトラヒドロフラン、ジオキサン
等のエーテル類;アセトン、メチルエチルケト
ン、シクロヘキサノン、アセトフエノン等のケト
ン類;酢酸メチル、酢酸エチル等のエステル類;
N・N−ジメチルホルムアミド、ジメチルスルホ
キシド、ヘキサメチルリン酸トリアミド等の非プ
ロトン性極性溶媒;アセトニトリル等のニトリル
類等が挙げられる。一般式〔〕の化合物と一般
式〔〕の化合物との使用割合としては特に限定
されず広い範囲から適宜選択されるが、反応を無
溶媒下で行なう場合には通常前者に対して後者を
等モル〜太過剰量使用するのがよく、また反応を
溶媒中で行なう場合には通常前者に対して後者を
等モル〜5倍モル、好ましくは等モル〜2倍モル
量使用するのがよい。該反応は一般に0〜200
℃、好ましくは50〜150℃の温度下に良好に進行
し、通常10分〜10時間、長くとも24時間以内に完
結する。
The above reaction in the present invention is carried out without a solvent or in a solvent. Any solvent can be used as long as it does not participate in the reaction. Typical solvents include alcohols such as methanol, ethanol, propanol, isopropanol, butanol, and ethylene glycol; ethers such as dimethyl ether, tetrahydrofuran, and dioxane; ketones such as acetone, methyl ethyl ketone, cyclohexanone, and acetophenone; methyl acetate; Esters such as ethyl acetate;
Examples include aprotic polar solvents such as N.N-dimethylformamide, dimethylsulfoxide, and hexamethylphosphoric triamide; and nitriles such as acetonitrile. The ratio of the compound of general formula [] and the compound of general formula [] to be used is not particularly limited and is appropriately selected from a wide range, but when the reaction is carried out without a solvent, the latter is usually equal to the former. It is preferable to use a molar to large excess amount, and when the reaction is carried out in a solvent, the latter is usually used in an equimolar to 5-fold molar amount, preferably an equimolar to 2-fold molar amount, relative to the former. The reaction is generally between 0 and 200
The process progresses well at a temperature of 50 to 150°C, and is usually completed within 10 minutes to 10 hours, and at most 24 hours.

反応終了後は常法に従い例えば過濃縮、結晶
化、再結晶等の通常の分離手段により反応液から
目的物を分離精製すればよい。
After completion of the reaction, the target product may be separated and purified from the reaction solution by conventional separation means such as overconcentration, crystallization, recrystallization, etc. in accordance with conventional methods.

かくして本発明の3・4−ジヒドロカルボスチ
リル誘導体が収得できる。
In this way, the 3,4-dihydrocarbostyryl derivative of the present invention can be obtained.

本発明化合物の製造例を以下に掲げる。 Production examples of the compounds of the present invention are listed below.

製造例 1 6−(3−ブロモプロポキシ)−3・4−ジヒド
ロカルボスチリル1.0gにピリジン20mlを加えて
75〜80℃にて10分間撹拌する。析出してくる結晶
を取し、エーテルで洗浄し乾燥する。得られた
結晶をエタノールから再結晶して無色針状晶の6
−(3−ピリジニウムプロポキシ)−3・4−ジヒ
ドロカルボスチリルブロマイド0.85gを得る。
Production example 1 Add 20 ml of pyridine to 1.0 g of 6-(3-bromopropoxy)-3,4-dihydrocarbostyryl.
Stir for 10 minutes at 75-80°C. Collect the precipitated crystals, wash with ether, and dry. The obtained crystals were recrystallized from ethanol to form colorless needle-like crystals.
0.85 g of -(3-pyridiniumpropoxy)-3,4-dihydrocarbostyryl bromide is obtained.

融点 190〜191.5℃ 製造例 2 6−(3−ブロモプロポキシ)−3・4−ジヒド
ロカルボスチリル1.0gにα−ピコリン4mlを加
えて90〜100℃にて3時間撹拌する。冷後析出晶
を取し、エーテルで洗浄し、エタノールから再
結晶して無色針状晶の6−(3−α−ピコリニウ
ムプロポキシ)−3・4−ジヒドロカルボスチリ
ルブロマイド1.3gを得る。
Melting point 190-191.5°C Production example 2 4 ml of α-picoline was added to 1.0 g of 6-(3-bromopropoxy)-3,4-dihydrocarbostyryl and stirred at 90-100°C for 3 hours. After cooling, the precipitated crystals were collected, washed with ether, and recrystallized from ethanol to obtain 1.3 g of 6-(3-α-picolinium propoxy)-3,4-dihydrocarbostyryl bromide in the form of colorless needles.

融点 179〜181℃Melting point 179-181℃

Claims (1)

【特許請求の範囲】 1 一般式 〔式中Rは水素原子又は炭素数1〜3のアルキル
基を、Xはハロゲン原子を夫々示す。〕 で表わされる3・4−ジヒドロカルボスチリル誘
導体。
[Claims] 1. General formula [In the formula, R represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms, and X represents a halogen atom. ] A 3,4-dihydrocarbostyryl derivative represented by:
JP9640377A 1977-08-10 1977-08-10 3,4-dihydrocarbostyril derivative Granted JPS5430180A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9640377A JPS5430180A (en) 1977-08-10 1977-08-10 3,4-dihydrocarbostyril derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9640377A JPS5430180A (en) 1977-08-10 1977-08-10 3,4-dihydrocarbostyril derivative

Publications (2)

Publication Number Publication Date
JPS5430180A JPS5430180A (en) 1979-03-06
JPS6129353B2 true JPS6129353B2 (en) 1986-07-05

Family

ID=14163986

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9640377A Granted JPS5430180A (en) 1977-08-10 1977-08-10 3,4-dihydrocarbostyril derivative

Country Status (1)

Country Link
JP (1) JPS5430180A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0215861Y2 (en) * 1984-12-22 1990-04-27
DK167187A (en) 1986-04-02 1987-10-03 Otsuka Pharma Co Ltd CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND MEDICINAL CONTAINING THESE
JPH0440039U (en) * 1990-06-02 1992-04-06

Also Published As

Publication number Publication date
JPS5430180A (en) 1979-03-06

Similar Documents

Publication Publication Date Title
SU575025A3 (en) Method of preparing 4-aryl-1,4-dihydroperidines or salts thereof
JPS6155514B2 (en)
JP2556722B2 (en) Novel sulfonamide compound
JPS6318588B2 (en)
JPS5929050B2 (en) Production method of cyclohexanedione-(1,3)
CH495981A (en) 2-oxoindolines bactericides analgesics diuretics
JPS6129353B2 (en)
JP2688712B2 (en) Method for producing halogen-substituted quinoline derivative
US2498497A (en) 2[2(phthalimido)ethyl]pyridines
SU701531A3 (en) Method of preparing oxime derivatives or their salts
JPH0378384B2 (en)
SU791230A3 (en) Method of preparing pyridinealkylsulfonic acid betain
JPS59176234A (en) P-nitrophenyl-3-bromo-2,2-diethoxy-propionate
JPS645024B2 (en)
JPH0148910B2 (en)
JP2937387B2 (en) Process for producing 5-substituted 2-amino-3-cyanopyrazines
JP4055246B2 (en) 5-chloro-6- (α-fluoroalkyl) -4-pyrimidone and process for producing the same
JPH0479343B2 (en)
JPS6125716B2 (en)
JPS5848555B2 (en) Calbostyril Yudou Tainoseinoseihou
JPS6219419B2 (en)
JPS60246384A (en) Chromone-8-carboxamide derivative
JPS596856B2 (en) Glycerol
JPS6346736B2 (en)
JPS637200B2 (en)